Dubinsky M C, Seidman E G
Division of Gastroenterology and Nutrition, Sainte Justine Hospital, Department of Pediatrics, University of Montreal, Montreal, Québec, Canada.
Curr Opin Gastroenterol. 2000 Jul;16(4):337-42. doi: 10.1097/00001574-200007000-00008.
The diagnosis of inflammatory bowel disease is usually straightforward, based on a detailed history and physical examination, along with standard radiographic and endoscopic investigations, biopsies, and laboratory parameters. More challenging is the search for clinically useful, noninvasive markers for Crohn disease and ulcerative colitis to accurately screen cases with nonspecific and indolent symptoms. Equally required are diagnostic markers that discriminate between these two disorders in cases with indeterminate colitis. Another dilemma for clinicians is that there are no simple measures to observe disease activity and predict relapses. This review describes the recent advances in diagnostic markers that afford the ability to screen for inflammatory bowel disease, discriminate between its types, and monitor disease activity. These include serological, fecal, and tissue markers; permeability tests; and diagnostic imaging using color Doppler ultrasonography.
炎症性肠病的诊断通常基于详细的病史、体格检查,以及标准的影像学和内镜检查、活检及实验室指标,相对较为直接。更具挑战性的是寻找对克罗恩病和溃疡性结肠炎临床有用的非侵入性标志物,以准确筛查具有非特异性和隐匿性症状的病例。对于诊断不确定的结肠炎病例,同样需要能够区分这两种疾病的诊断标志物。临床医生面临的另一个困境是,没有简单的方法来观察疾病活动和预测复发。本综述描述了诊断标志物的最新进展,这些标志物能够筛查炎症性肠病、区分其类型并监测疾病活动。这些标志物包括血清学、粪便和组织标志物;通透性测试;以及使用彩色多普勒超声的诊断成像。